Prevention of Sudden Death in Patients with Genetic Arrhythmias

  • Pietro Delise
Conference paper


In recent years a number of genetic heart diseases have been recognized that can be complicated by malignant arrhythmias leading to sudden death [1]. These genetic diseases can be divided into two groups: (1) channelopathies (congenital dysfunction of cellular ion-channels without macroscopic heart disease) and (2) genetic cardiomyopathies.


Sudden Death Sudden Cardiac Death Brugada Syndrome Catecholaminergic Polymorphic Ventricular Tachycardia Malignant Arrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sarkozy A, Brugada P (2005) Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol 16:S8–S20PubMedCrossRefGoogle Scholar
  2. 2.
    Jervell A, Lange-Nielsen F (1957) Congenital deaf mutism, functional heart disease with prolongation of the QT interval and sudden death. Am Heart J 54:59–68PubMedCrossRefGoogle Scholar
  3. 3.
    Romano C, Gemme G, Pongiglione R (1963) Aritmie cardiache rare dell’età pediatrica, II: accessi sincopali per fibrillazione ventricolare parossistica. Clin Pediatr (Bologna) 45:656–683Google Scholar
  4. 4.
    Schwartz PJ (1985) Idiopathic long QT syndrome: progress and questions. Am Heart J 109:399–411PubMedCrossRefGoogle Scholar
  5. 5.
    Marks ML, Trippel DL, Keating MT (1995) Long QT syndrome associated with syndactyly identified in females. Am J Cardiol 76:744–745PubMedCrossRefGoogle Scholar
  6. 6.
    Duggal P, Vesely MR, Wattanasirichaigoon D et al (1998) Mutation of the gene for IsK associated with both Jervell and Lang-Nielsen and Romano-Ward forms of long QT syndromes. Circulation 97:142–146PubMedGoogle Scholar
  7. 7.
    Locati EH, Zareba W, Moss AJ et al (1998) Age-and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97:2237–2244PubMedGoogle Scholar
  8. 8.
    Priori SG, Schwartz PJ, Napolitano C et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874PubMedCrossRefGoogle Scholar
  9. 9.
    Napolitano C, Bloise R, Priori S (2006) Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sport activity. J Cardiovasc Med 7:250–256Google Scholar
  10. 10.
    Gaita F, Giustetto C, Bianchi F et al (2003) Short QT syndrome. A familial cause of sudden death. Circulation 108:965–970PubMedCrossRefGoogle Scholar
  11. 11.
    Brugada R, Hong K, Dumaine R et al (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109:30–35PubMedCrossRefGoogle Scholar
  12. 12.
    Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20:1391–1396PubMedCrossRefGoogle Scholar
  13. 13.
    Brugada R, Brugada J, Antzelevitch C et al (2000) Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101:510–515PubMedGoogle Scholar
  14. 14.
    Brugada P, Brugada R, Mont L et al (2003) Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovas Electrophysiol 14:455–457CrossRefGoogle Scholar
  15. 15.
    Priori SG, Napolitano C, Gasparini M et al (2002) Natural history of Brugada syndrome. Insight for risk stratification and management. Circulation 105:1342–1347PubMedCrossRefGoogle Scholar
  16. 16.
    Antzelevitch C, Brugada P, Borggrefe M et al (2006) Brugada syndrome. Report of the second consensus conference. Circulation 111:659–670CrossRefGoogle Scholar
  17. 17.
    Delise P, Marras E, Bocchino M (2006) Brugada-like electrocardiogram pattern: how to stratify the risk for sudden cardiac death. Is sport activity contraindicated? J Cardiovasc Med 7:239–245CrossRefGoogle Scholar
  18. 18.
    Coumel P, Fidelle J, Lucet V et al (1978) Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J 40:28–37Google Scholar
  19. 19.
    Leenhardt A, Lucet V, Denjoy I et al (1995) Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91:1512–1519PubMedGoogle Scholar
  20. 20.
    Gasparini M, Priori S, Mantica M et al (2002) Programmed electrical stimulation in Brugada syndrome: how reproducible are the results? J Cardiovasc Electrophysiol 13:880–887PubMedCrossRefGoogle Scholar
  21. 21.
    Kanda M, Shimizu W, Matsuo K et al (2002) Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 39:1799–1805PubMedCrossRefGoogle Scholar
  22. 22.
    Eckardt L, Probst V, Smits JP et al (2005) Long-term prognosis of individuals with right precordial ST-segment elevation Brugada syndrome. Circulation 111:257–263PubMedCrossRefGoogle Scholar
  23. 23.
    Brugada J, Brugada R, Brugada P (2003) Determinants of sudden death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 108:3092–3096PubMedCrossRefGoogle Scholar
  24. 24.
    ACC/AHA/ESC (2006) 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death — Executive summary. Eur Heart J 27:2099–2140CrossRefGoogle Scholar
  25. 25.
    Belhassen B, Viskin S, Fish R et al (1999) Effects of electrophysiologic-guided therapy with Class IA antiarrhyhtmic drugs on the long term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 10:1301–1312PubMedCrossRefGoogle Scholar
  26. 26.
    Hermida JS, Denjoy I, Clerc J et al (2004) Hydroquinidine therapy in Brugada Syndrome. J Am Coll Cardiol 43:1853–1860PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Pietro Delise
    • 1
  1. 1.Cardiology Operative UnitConegliano HospitalConegliano (TV)Italy

Personalised recommendations